CARA
Cara Therapeutics Inc
Price:  
5.20 
USD
Volume:  
22,838.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA Relative Valuation

-6973.7%
Upside

As of 2025-02-17, the Relative Valuation of Cara Therapeutics Inc (CARA) is (357.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.20 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -6973.7%.

The range of the Relative Valuation is (311.03) - (407.18) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.9x - 19.5x 17.3x
Forward P/E multiples 14.3x - 20.2x 16.9x
Fair Price (311.03) - (407.18) (357.43)
Upside -6081.4% - -7930.4% -6973.7%
5.20 USD
Stock Price
(357.43) USD
Fair Price

CARA Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -0.24
2025-02-06 -0.24
2025-02-05 -0.24
2025-02-04 -0.23
2025-02-03 -0.23
2025-01-31 -0.23
2025-01-30 -0.24
2025-01-29 -0.24
2025-01-28 -0.23
2025-01-27 -0.26
2025-01-24 -0.29
2025-01-23 -0.24
2025-01-22 -0.23
2025-01-21 -0.22
2025-01-17 -0.22
2025-01-16 -0.22
2025-01-15 -0.21
2025-01-14 -0.22
2025-01-13 -0.22
2025-01-10 -0.23
2025-01-08 -0.23
2025-01-07 -0.23
2025-01-06 -0.25
2025-01-03 -0.25
2025-01-02 -0.26
2024-12-31 -0.29
2024-12-30 -0.20
2024-12-27 -0.22
2024-12-26 -0.26
2024-12-24 -0.27
2024-12-23 -0.26
2024-12-20 -0.24
2024-12-19 -0.23
2024-12-18 -0.15
2024-12-17 -0.14
2024-12-16 -0.15
2024-12-13 -0.15
2024-12-12 -0.15
2024-12-11 -0.15
2024-12-10 -0.16
2024-12-09 -0.17
2024-12-06 -0.15
2024-12-05 -0.15
2024-12-04 -0.16
2024-12-03 -0.16
2024-12-02 -0.17
2024-11-29 -0.17
2024-11-27 -0.17
2024-11-26 -0.17
2024-11-25 -0.17